Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Celexa
2. Citalopram
3. Cytalopram
4. Lu-10-171
5. Lu10171
6. Seropram
1. 59729-32-7
2. Citalopram Hbr
3. Celexa
4. Cipramil
5. 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
6. Elopram
7. Seropram
8. Bonitrile Hbr
9. Nitalapram Hbr
10. Lu 10-171-b
11. Citalopram (hydrobromide)
12. Citalopram, Hydrobromide Salt
13. Lu 10-171 Hbr
14. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;hydrobromide
15. Nsc-758684
16. Citalopram (as Hydrobromide)
17. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Hydrobromide
18. I1e9d14f36
19. Cipram
20. (s)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
21. Lu 10-171
22. Lu-10-171-b
23. Citalopram D4 Hbr
24. 59729-32-7 (hbr)
25. 1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile Monohydrobromide
26. 5-isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, Monohydrobromide
27. Prepram Hbr
28. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Hydrobromide
29. Smr000326936
30. Citalopram Hydrobromide [usan]
31. Lu-10-171
32. Sr-01000003129
33. 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Monohydrobromide
34. Einecs 261-890-6
35. C20h21fn2o.hbr
36. Apertia
37. Prisdal
38. Lupram
39. Sepram
40. Unii-i1e9d14f36
41. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
42. Citalopram Hydrobromide [usan:usp]
43. Celexa (tn)
44. Mfcd02101306
45. Cpd000326936
46. Schembl1118
47. Mls000758293
48. Mls000860078
49. Mls001401376
50. Mls002222294
51. Citalopram Hydrobromide (usp)
52. Citalopram Hydrobromide Solution
53. Chembl1200781
54. Dtxsid40872344
55. Pharmakon1600-01504172
56. Citalopram Hydrogen Bromide- Bio-x
57. Hy-b1287
58. Lu-10-171b
59. Citalopram Hydrobromide [mi]
60. Tox21_500258
61. Nsc758684
62. S4749
63. Zd 211
64. Zd-211
65. Citalopram Hydrobromide [hsdb]
66. Akos005145738
67. Ab10921
68. Ac-1595
69. Bcp9000537
70. Ccg-101022
71. Ccg-213271
72. Citalopram Hydrobromide [mart.]
73. Citalopram Hydrobromide [vandf]
74. Cs-4735
75. Ks-1043
76. Lp00258
77. Nc00272
78. Nsc 758684
79. Citalopram Hydrobromide [usp-rs]
80. Citalopram Hydrobromide [who-dd]
81. Ncgc00093717-01
82. Ncgc00093717-02
83. Ncgc00093717-03
84. Ncgc00260943-01
85. Bc164316
86. Citalopram Hydrobromide, >=98% (hplc)
87. Citalopram Hydrobromide [orange Book]
88. Eu-0100258
89. Ft-0600173
90. Citalopram Hydrobromide [ep Monograph]
91. Citalopram Hydrobromide [usp Impurity]
92. C 7861
93. C75790
94. Citalopram Hydrobromide [usp Monograph]
95. D00822
96. 729c327
97. A832439
98. Q-200865
99. Sr-01000003129-2
100. Sr-01000003129-4
101. W-105304
102. Citalopram Hydrobromide 100 Microg/ml In Acetonitrile
103. Q27280253
104. Sr-01000003129-10
105. Z1550648760
106. Citalopram Hydrobromide 0.1 Mg/ml In Methanol (as Free Base)
107. Citalopram Hydrobromide 1.0 Mg/ml In Methanol (as Free Base)
108. Citalopram Hydrobromide, European Pharmacopoeia (ep) Reference Standard
109. Citalopram Hydrobromide, United States Pharmacopeia (usp) Reference Standard
110. 1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile Monohbr
111. Citalopram For System Suitability, European Pharmacopoeia (ep) Reference Standard
112. Citalopram Hydrobromide, Pharmaceutical Secondary Standard; Certified Reference Material
113. 1-(3-dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile Hydrobromide
114. 1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carbonitrile Hbr
115. 1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
116. 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitril E Hydrobromide
117. 5-isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, Monohbr
118. 5-isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, Hydrobromide (1:1)
119. Citalopram Hydrobromide Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
120. Citalopram Hydrobromide Solution, 100 Mug/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 405.3 g/mol |
---|---|
Molecular Formula | C20H22BrFN2O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 404.08995 g/mol |
Monoisotopic Mass | 404.08995 g/mol |
Topological Polar Surface Area | 36.3 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 466 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Celexa |
Active Ingredient | Citalopram hydrobromide |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 40mg base; eq 20mg base; eq 10mg base |
Market Status | Prescription |
Company | Forest Labs |
2 of 4 | |
---|---|
Drug Name | Citalopram hydrobromide |
PubMed Health | Citalopram (By mouth) |
Drug Classes | Antidepressant |
Active Ingredient | Citalopram hydrobromide |
Dosage Form | Tablet; Capsule; Solution |
Route | orally disintegrating; Oral |
Strength | eq 40mg base; eq 10mg base/5ml; eq 20mg base; eq 10mg base; 40mg |
Market Status | Prescription |
Company | Mylan Pharms; Glenmark Generics; Silarx; Amneal Pharms Ny; Teva Pharms; Epic Pharma; Apotex; Aurobindo; Aurobindo Pharma; Sun Pharm Inds; Torrent Pharms; Dr Reddys Labs; Pliva; Invagen Pharms; Cipla; Mylan; Roxane; Biovail Labs Intl |
3 of 4 | |
---|---|
Drug Name | Celexa |
Active Ingredient | Citalopram hydrobromide |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 40mg base; eq 20mg base; eq 10mg base |
Market Status | Prescription |
Company | Forest Labs |
4 of 4 | |
---|---|
Drug Name | Citalopram hydrobromide |
PubMed Health | Citalopram (By mouth) |
Drug Classes | Antidepressant |
Active Ingredient | Citalopram hydrobromide |
Dosage Form | Tablet; Capsule; Solution |
Route | orally disintegrating; Oral |
Strength | eq 40mg base; eq 10mg base/5ml; eq 20mg base; eq 10mg base; 40mg |
Market Status | Prescription |
Company | Mylan Pharms; Glenmark Generics; Silarx; Amneal Pharms Ny; Teva Pharms; Epic Pharma; Apotex; Aurobindo; Aurobindo Pharma; Sun Pharm Inds; Torrent Pharms; Dr Reddys Labs; Pliva; Invagen Pharms; Cipla; Mylan; Roxane; Biovail Labs Intl |
Selective Serotonin Reuptake Inhibitors
Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36925
Submission : 2023-05-22
Status : Active
Type : II
Certificate Number : R0-CEP 2021-437 - Rev 00
Issue Date : 2023-08-29
Type : Chemical
Substance Number : 2288
Status : Valid
NDC Package Code : 51686-0007
Start Marketing Date : 2024-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25065
Submission : 2011-06-16
Status : Active
Type : II
NDC Package Code : 47621-022
Start Marketing Date : 2012-08-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-08-15
Pay. Date : 2023-08-11
DMF Number : 20586
Submission : 2007-06-04
Status : Active
Type : II
Certificate Number : R1-CEP 2010-037 - Rev 01
Issue Date : 2020-07-17
Type : Chemical
Substance Number : 2288
Status : Valid
NDC Package Code : 64220-105
Start Marketing Date : 2011-02-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23979
Submission : 2010-07-19
Status : Active
Type : II
Certificate Number : R1-CEP 2011-214 - Rev 00
Issue Date : 2017-09-14
Type : Chemical
Substance Number : 2288
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20094
Submission : 2006-12-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17511
Submission : 2004-07-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17104
Submission : 2004-01-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36925
Submission : 2023-05-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16045
Submission : 2002-07-11
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16850
Submission : 2003-09-19
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16553
Submission : 2003-04-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15813
Submission : 2002-01-17
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12384
Submission : 1997-02-24
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-03-15
Pay. Date : 2013-03-05
DMF Number : 15587
Submission : 2001-08-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15836
Submission : 2002-01-31
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16961
Submission : 2003-11-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16788
Submission : 2003-08-26
Status : Inactive
Type : II
Certificate Number : R0-CEP 2021-437 - Rev 00
Status : Valid
Issue Date : 2023-08-29
Type : Chemical
Substance Number : 2288
Certificate Number : R1-CEP 2009-012 - Rev 01
Status : Valid
Issue Date : 2018-02-08
Type : Chemical
Substance Number : 2288
Certificate Number : R1-CEP 2010-222 - Rev 00
Status : Valid
Issue Date : 2017-01-27
Type : Chemical
Substance Number : 2288
Certificate Number : R1-CEP 2010-296 - Rev 00
Status : Valid
Issue Date : 2016-12-08
Type : Chemical
Substance Number : 2288
Certificate Number : R1-CEP 2009-175 - Rev 05
Status : Valid
Issue Date : 2023-07-10
Type : Chemical
Substance Number : 2288
Citalopram hydrobromide, DGR process
Certificate Number : R1-CEP 2010-379 - Rev 02
Status : Valid
Issue Date : 2022-08-24
Type : Chemical
Substance Number : 2288
Certificate Number : R1-CEP 2009-390 - Rev 01
Status : Valid
Issue Date : 2017-02-14
Type : Chemical
Substance Number : 2288
Certificate Number : R1-CEP 2010-228 - Rev 02
Status : Valid
Issue Date : 2022-10-05
Type : Chemical
Substance Number : 2288
Certificate Number : R1-CEP 2011-214 - Rev 00
Status : Valid
Issue Date : 2017-09-14
Type : Chemical
Substance Number : 2288
Certificate Number : R1-CEP 2009-304 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2017-05-22
Type : Chemical
Substance Number : 2288
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?